IRIX Pharmaceuticals

Florence, United States Founded: 1996 • Age: 30 yrs Acquired By Patheon
Difficult-to-manufacture APIs and complex intermediates are developed by IRIX Pharmaceuticals.

About IRIX Pharmaceuticals

IRIX Pharmaceuticals is a Healthcare company based in Florence (United States) founded in 1996, and was acquired by Patheon in March 2015. Difficult-to-manufacture APIs and complex intermediates are developed by IRIX Pharmaceuticals. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production.

Company details

IRIX Pharmaceuticals was established in 1996 in Florence, United States, as a contract research and manufacturing organization in the pharmaceutical sector. It was acquired by Patheon in 2015. Services encompass process research, development, and production of challenging active pharmaceutical ingredients from preclinical stages through commercial manufacturing, including stability studies and regulatory support. Operations extend to clients across North America, Europe, Asia, and Australia.

  • Headquarters Florence, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website irixpharma.com
  • Social LinkedIn
  • Acquired by Patheon (Mar 2015)
Key Metrics

Investors in IRIX Pharmaceuticals

IRIX Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Patheon.

All
InvestorDescriptionFounded YearDomainLocation
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
1974patheon.comDurham, United States
Premium access

Investor details for IRIX Pharmaceuticals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of IRIX Pharmaceuticals

2 dated milestones of IRIX Pharmaceuticals across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded IRIX Pharmaceuticals is founded.
  2. Exit Acquired by Patheon.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as IRIX Pharmaceuticals (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about IRIX Pharmaceuticals

IRIX Pharmaceuticals was founded in 1996.

IRIX Pharmaceuticals is headquartered in Florence, United States.

IRIX Pharmaceuticals was established in 1996 in Florence, United States, as a contract research and manufacturing organization in the pharmaceutical sector. It was acquired by Patheon in 2015. Services encompass process research, development, and production of challenging active pharmaceutical ingredients from preclinical stages through commercial manufacturing, including stability studies and regulatory support. Operations extend to clients across North America, Europe, Asia, and Australia.

IRIX Pharmaceuticals has 1 investor. Key investors include Patheon.

Yes. IRIX Pharmaceuticals was acquired by Patheon in March 2015.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available